Piper Sandler adjusted its financial outlook for Amazon.com (NASDAQ:AMZN), increasing the price target to $265 from the previous $225, while maintaining an Overweight rating on the company's shares.
Piper Sandler analyst Adam Maeder upgraded shares of Nevro Corp (NYSE:NVRO), a medical device company with a market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback